Cell BioEngines
New York · Founded 2022
About Cell BioEngines
Cell BioEngines is a US-based clinical-stage biotechnology company pioneering off-the-shelf, allogeneic cell therapies. Leveraging cord blood stem cells from highly compatible super-donors and powered by its proprietary STEM-Space platform, the company delivers scalable cell products with reduced risk of immune rejection. Cell BioEngines’ competitive edge comes from a unique combination of a transgene-free manufacturing platform enabled by advanced biological/chemical programming, rigorous HLA-guided design, and a population-informed biobank that supports broad patient coverage. For more information, visit www.cellbioengines.com
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $13.9M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: https://cellbioengines.com/
- Phone: 617-899-2364
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cell-bioengines-16623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.